Compass Therapeutics, Inc. — Balance Sheet Charts
11 snapshots of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Assets vs Liabilities
Cash Position Breakdown
Working Capital Components
Total Assets↑+56.4% +$79M
$220M
Current Assets↑+58.1% +$77M
$210M
Cash & Equivalents↓-29.5% -$13M
$31M
ST Investments↑+114.2% +$95M
$178M
Net PPE↓-71.1% -$251K
$102K
Total Liabilities↑+50.3% +$8M
$23M
Current Liabilities↑+57.4% +$5M
$14M
Account Payables↓-29.5% -$664K
$2M
Long-Term Debt
—
Stockholders Equity↑+57.1% +$72M
$197M
Retained Earnings↓-18.2% -$66M
$-431M
Operating Lease ROU Asset↑+35.2% +$2M
$9M
Operating Lease Liability↑+40.2% +$3M
$9M
Gross PP&E↑+0.4% +$25K
$7M
Accumulated Depreciation↑+4.3% +$276K
$7M